![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2022/09/14/2516028/0/en/Veritas-Collaborative-Partners-With-Project-HEAL-to-Make-Large-Scale-Commitment-to-Equitable-Eating-Disorder-Treatment-Access-in-Atlanta.html
https://www.prnewswire.com/news-releases/grunenthal-and-averitas-pharma-announce-initiation-of-phase-iii-study-with-qutenza-to-prepare-label-extension-in-the-us-for-the-treatment-of-post-surgical-neuropathic-pain-301258564.html
https://www.thepharmaletter.com/article/growth-for-grunenthal-with-new-qutenza-indication
https://www.grunenthal.com/en/press-room/press-releases/us-fda-approval-of-qutenza-for-the-treatment-of-neuropathic-pain-associated-with-dpn-of-the-feet
https://www.prnewswire.com/news-releases/averitas-pharma-announces-fda-acceptance-of-snda-filing-for-qutenza-capsaicin-8-patch-for-the-treatment-of-neuropathic-pain-associated-with-diabetic-peripheral-neuropathy-300976908.html